Publications - Gerald Fletcher, M.D.

Back to research profile

  1. Beckie TM, Beckstead JW, Kip K, Fletcher G. Physiological and exercise capacity improvements in women completing cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2013 Jan-Feb; 33(1):16-25.
    View PubMed
  2. Beckie TM, Beckstead JW, Kip KE, Fletcher G. Improvements in Heart Rate Recovery Among Women After Cardiac Rehabilitation Completion. J Cardiovasc Nurs. 2012 Nov 14. [Epub ahead of print]
    View PubMed
  3. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012 Oct 30; 126(18):2261-74. Epub 2012 Sep 05.
    View PubMed
  4. Fletcher GF, Berra K, Fletcher BJ, Gilstrap L, Wood MJ. The integrated team approach to the care of the patient with cardiovascular disease. Curr Probl Cardiol. 2012 Sep; 37(9):369-97.
    View PubMed
  5. Horwich TB, Broderick S, Chen L, McCullough PA, Strzelczyk T, Kitzman DW, Fletcher G, Safford RE, Ewald G, Fine LJ, Ellis SJ, Fonarow GC. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011 Dec 15; 108(12):1754-9. Epub 2011 Sep 09.
    View PubMed
  6. Whellan DJ, Nigam A, Arnold M, Starr AZ, Hill J, Fletcher G, Ellis SJ, Cooper L, Onwuanyi A, Chandler B, Keteyian SJ, Ewald G, Kao A, Gheorghiade M. Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study. Am Heart J. 2011 Dec; 162(6):1003-10.
    View PubMed
  7. Beckie TM, Beckstead JW, Schocken DD, Evans ME, Fletcher GF. The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: A randomized clinical trial. Int J Nurs Stud. 2011 Jan; 48(1):3-12. Epub 2010 Jul 07.
    View PubMed
  8. Paterick TE, Paterick ZR, Fletcher G. Informed consent and transesophageal echocardiography: a review of patient responses. Int J Cardiol. 2010 Sep 3; 143(3):227-9. Epub 2010 Mar 04.
    View PubMed
  9. Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, Kumanyika S, Kraus WE, Fleg JL, Redeker NS, Meininger JC, Banks J, Stuart-Shor EM, Fletcher BJ, Miller TD, Hughes S, Braun LT, Kopin LA, Berra K, Hayman LL, Ewing LJ, Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation. 2010 Jul 27; 122(4):406-41. Epub 2010 Jul 12.
    View PubMed
  10. Coke LA, Fletcher GF. Exercise and the cardiac patient-success is just steps away. J Cardiovasc Nurs. 2010 May-Jun; 25(3):238-40.
    View PubMed
  11. Paterick ZR, Fletcher G, Paterick TE. A soccer scholarship. Prev Cardiol. 2010 Spring; 13(2):91-3.
    View PubMed
  12. Paterick TE, Paterick ZR, Fletcher GF. A case study of healthcare fraud. J Med Pract Manage. 2010 Jan-Feb; 25(4):243-4.
    View PubMed
  13. Forman DE, Clare R, Kitzman DW, Ellis SJ, Fleg JL, Chiara T, Fletcher G, Kraus WE, HF-ACTION Investigators. Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study. Am Heart J. 2009 Oct; 158(4 Suppl):S6-S15.
    View PubMed
  14. Gottlieb SS, Kop WJ, Ellis SJ, Binkley P, Howlett J, O'Connor C, Blumenthal JA, Fletcher G, Swank AM, Cooper L, HF-ACTION Investigators. Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). Am J Cardiol. 2009 May 1; 103(9):1285-9. Epub 2009 Feb 28.
    View PubMed
  15. Beckie TM, Mendonca MA, Fletcher GF, Schocken DD, Evans ME, Banks SM. Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial. J Cardiopulm Rehabil Prev. 2009 Jan-Feb; 29(1):13-21; quiz 22-3.
    View PubMed
  16. Brown WV, Fletcher GF, Wilson PW. Using exercise to reduce risk[dagger]. J. Clin. Lipidology. 2009; 3(6):360-7.
  17. Jneid H, Fonarow GC, Cannon CP, Palacios IF, Kilic T, Moukarbel GV, Maree AO, LaBresh KA, Liang L, Newby LK, Fletcher G, Wexler L, Peterson E, Get With the Guidelines Steering Committee and Investigators. Impact of time of presentation on the care and outcomes of acute myocardial infarction. Circulation. 2008 May 13; 117(19):2502-9. Epub 2008 Apr 21.
    View PubMed
  18. Beckie TM, Fletcher GF, Beckstead JW, Schocken DD, Evans ME. Adverse baseline physiological and psychosocial profiles of women enrolled in a cardiac rehabilitation clinical trial. J Cardiopulm Rehabil Prev. 2008 Jan-Feb; 28(1):52-60.
    View PubMed
  19. Osborn RQ, Taylor WC, Oken K, Luzano M, Heckman M, Fletcher G. Echocardiographic characterisation of left ventricular geometry of professional male tennis players. Br J Sports Med. 2007 Nov; 41(11):789-92; discussion 792. Epub 2007 Aug 21.
    View PubMed
  20. Arena R, Myers J, Williams MA, Gulati M, Kligfield P, Balady GJ, Collins E, Fletcher G, American Heart Association Committee on Exercise, Rehabilitation and Prevention of the Council on Clinical Cardiology, American Heart Association Council on Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation. 2007 Jul 17; 116(3):329-43. Epub 2007 Jun 18.
    View PubMed
  21. Trejo-Gutierrez JF, Fletcher G. Impact of exercise on blood lipids and lipoproteins. J Clin Lipidol. 2007 Jul; 1(3):175-81. Epub 2007 Jun 07.
    View PubMed
  22. Fletcher GF, Bufalino V, Costa F, Goldstein LB, Jones D, Smaha L, Smith SC Jr, Stone N. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Am J Cardiol. 2007 Mar 27; 99(6C):1E-35E. Epub 2007 Mar 05.
    View PubMed
  23. Nyquist-Battie C, Fletcher GF, Fletcher B, Carlson JM, Castello R, Oken K. Upper-extremity exercise training in heart failure. J Cardiopulm Rehabil Prev. 2007 Jan-Feb; 27(1):42-5.
    View PubMed
  24. Fletcher GF, Mills WC, Taylor WC. Update on exercise stress testing. Am Fam Physician. 2006 Nov 15; 74(10):1749-54.
    View PubMed
  25. Paterick TE, Paterick TJ, Fletcher GF, Maron BJ. Medical and legal issues in the cardiovascular evaluation of competitive athletes. JAMA. 2005 Dec 21; 294(23):3011-8.
    View PubMed
  26. King ML, Williams MA, Fletcher GF, Gordon NF, Gulanick M, King CN, Leon AS, Levine BD, Costa F, Wenger NK, American Heart Association, American Association for Cardiovascular and Pulmonary Rehabilitation. Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: a scientific statement from the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005 Nov 22; 112(21):3354-60.
    View PubMed
  27. King ML, Williams MA, Fletcher GF, Gordon NF, Gulanick M, King CN, Leon AS, Levine BD, Costa F, Wenger NK, American Association for Cardiovascular and Pulmonary Rehabilitation, American Heart Association. Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs. A statement for healthcare professionals from the American Association for Cardiovascular and Pulmonary Rehabilitation and the American Heart Association. J Cardiopulm Rehabil. 2005 Nov-Dec; 25(6):315-20.
    View PubMed
  28. Fletcher G, Trejo-Gutierrez JF. Why and how to prescribe exercise: Overcoming the barriers. Cleve Clin J Med. 2005 Aug; 72(8):645-56.
    View PubMed
  29. Bueno N, Fletcher BJ, Fletcher GF, Serra S, Cruz PM, Kelly D, Meirelles L, Atkinson E, Tabor LA, Ramos A, Castro I. Coronary risk factors in adult children of parents with coronary heart disease: a comparison survey of southeastern Brazil and southeastern United States. Prev Cardiol. 2005 Summer; 8(3):149-54.
    View PubMed
  30. Fletcher BJ, Berra K, Ades P, Fletcher GF, et al. Managing abnormal blood lipids - a collaborative approach. Circulation. 2005; 112:3186-209.
  31. Gordon NF, Gulanick M, Costa F, Fletcher G, Franklin BA, Roth EJ, Shephard T, et al. Physical activity and exercise recommendations for stroke survivors. Circulation. 2004 Apr 27; 109(16):2031-41.
    View PubMed
  32. Trejo JF, Safford RE, Fletcher GF. Work to do in preventive cardiology. Proc (Bayl Univ Med Cent) 2004 Apr; 17(2):104-5.
    View PubMed
  33. Fletcher GF. Combating the Metabolic Syndrome and Obesity. J. Am. Coll. Cardiol. Current Journal Review. 2004; 13:20-22.
  34. Oken K, Fletcher G. Benefits of aggressive drug therapy. J Cardiovasc Nurs. 2003 Apr-Jun; 18(2):79-84.
    View PubMed
  35. Thompson PD, Fletcher GF, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Circulation. 2003; 107:3109-16.
    View PubMed
  36. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002 Oct 1; 106(14):1883-92.
    View PubMed
  37. Fletcher GF. Improving Preventive Cardiology: The 33rd Bethesda Conference Preventive Cardiology. 2002 Fall:204-205.
  38. Fletcher GF, Balady GJ, et al. Bethesda Conference No. 33. Preventive cardiology: how can we do better. J Am Coll Cardiol. 2002; 40:579-651.
  39. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001 Oct 2; 104(14):1694-740.
    View PubMed
  40. Patton JN, Fletcher G. Aggressive secondary prevention: a perspective from the coronary interventional setting. J Interv Cardiol. 2001 Oct; 14(5):559-62.
    View PubMed
  41. Paterick TE, Fletcher GF. Endothelial function and cardiovascular prevention: role of blood lipids, exercise, and other risk factors. Cardiol Rev. 2001 Sep-Oct; 9(5):282-6.
    View PubMed
  42. Kim JR, Oberman A, Fletcher GF, Lee JY. Effect of exercise intensity and frequency on lipid levels in men with coronary heart disease: Training Level Comparison Trial. Am J Cardiol. 2001 Apr 15; 87(8):942-6; A3.
    View PubMed
  43. Maron BJ, Araujo CG, Thompson PD, Fletcher GF, de Luna AB, Fleg JL, Pelliccia A, Balady GJ, Furlanello F, Van Camp SP, Elosua R, Chaitman BR, Bazzarre TL, World Heart Federation, International Federation of Sports Medicine, American Heart Association Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2001 Jan 16; 103(2):327-34.
    View PubMed
  44. Taylor WC, Fletcher GF. Cardiovascular disease in athletes. Cardiovasc Rev Rep. 2001; 22(9):530-536.
  45. Ades PA, Pashkow FJ, Fletcher G, Pina IL, Zohman LR, Nestor JR. A controlled trial of cardiac rehabilitation in the home setting using electrocardiographic and voice transtelephonic monitoring. Am Heart J. 2000 Mar; 139(3):543-8.
    View PubMed
  46. Smith SC Jr, Amsterdam E, Balady GJ, Bonow RO, Fletcher GF, Froelicher V, Heath G, Limacher MC, Maddahi J, Pryor D, Redberg RF, Roccella E, Ryan T, Smaha L, Wenger NK. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II. Circulation. 2000 Jan 4; 101(1):E12-6.
    View PubMed
  47. Fletcher G. Physical inactivity as a risk factor for cardiovascular disease. Am J Med. 1999; 107(2 Suppl 1):10-11.
    View PubMed
  48. Fletcher GF. Current status of cardiac rehabilitation. Am Fam Physician. 1998 Nov 15; 58(8):1778-82.
    View PubMed
  49. Fletcher GF, Flipse TR, Kligfield P, Malouf JR. Current status of ECG stress testing. Curr Probl Cardiol. 1998 Jul; 23(7):353-423.
    View PubMed
  50. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, Ockene IS, Pearson TA, Reed J, Washington R, Smith SC Jr. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation. 1998 May 12; 97(18):1876-87.
    View PubMed
  51. Miller TD, Fletcher GF. Exercise and coronary artery disease prevention. Cardiologia. 1998 Jan; 43(1):43-51.
    View PubMed
  52. Franklin BA, Fletcher GF, Gordon NF, Noakes TD, Ades PA, Balady GJ. Cardiovascular evaluation of the athlete. Issues regarding performance, screening and sudden cardiac death. Sports Med. 1997 Aug; 24(2):97-119.
    View PubMed
  53. Fletcher GF. How to implement physical activity in primary and secondary prevention. A statement for healthcare-professionals from the Task Force on Risk-reduction, American Heart Association. Circulation. 1997 Jul 1; 96(1):355-7.
    View PubMed
  54. Miller TD, Balady GJ, Fletcher GF. Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Ann Behav Med. 1997 Summer; 19(3):220-9.
    View PubMed
  55. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, Ockene IS, Pearson TA, Reed J, Washington R, Smith SC Jr. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. Circulation. 1997 May 6; 95(9):2329-31.
    View PubMed
  56. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, Ockene IS, Pearson TA, Reed J, Smith SC Jr, Washington R. When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. Circulation. 1997 Mar 18; 95(6):1683-5.
    View PubMed
  57. Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, Sivarajan Froelicher ES, Froelicher VF, Pina IL, Pollock ML. Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1996 Aug 15; 94(4):857-62.
    View PubMed
  58. Jensen BE, Fletcher BJ, Rupp JC, Fletcher GF, Lee JY, Oberman A. Training level comparison study. Effect of high and low intensity exercise on ventilatory threshold in men with coronary artery disease. J Cardiopulm Rehabil. 1996 Jul-Aug; 16(4):227-32.
    View PubMed
  59. Grundy S, Balady GJ, Criqui M, Fletcher GF, et al. Cholesterol screening in asymptomatic adults. No cause to change. Task Force on Risk Reduction, American Heart Association. Circulation. 1996 Mar 15; 93(6):1067-8.
    View PubMed
  60. Fletcher GF. The antiatherosclerotic effect of exercise and development of an exercise prescription. Cardiol Clin. 1996 Feb; 14(1):85-95.
    View PubMed
  61. Lee JY, Jensen BE, Oberman A, Fletcher GF, Fletcher BJ, Raczynski JM. Adherence in the training levels comparison trial. Med Sci Sports Exerc. 1996 Jan; 28(1):47-52.
    View PubMed
  62. Fletcher GF. Exercise standards. Circulation. 1995 Dec 15; 92(12):3580.
  63. Oberman A, Fletcher GF, Lee J, Nanda N, Fletcher BJ, Jensen B, Caldwell ES. Efficacy at high-intensity exercise training on left ventricular ejection fraction men with coronary artery disease. (The training level comparison study). Am J Cardiol. 1995 Oct 1; 76:643-647.
    View PubMed
  64. Smith SC Jr, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, Gotto AM, Gould KL, Greenland P, Grundy SM, et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995 Jul 1; 92(1):2-4.
    View PubMed
  65. Smith SC Jr, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, Gotto AM, Gould KL, Greenland P, Grundy SM, et al. AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol. 1995 Jul; 26(1):292-4.
    View PubMed
  66. Fletcher GF, Fletcher BJ, Whitner JT, Staggers J, Almon L. Effects of variable doses and formulations of cholestyramine on elevated serum low-density lipoprotein cholesterol. Am J Cardiol. 1995 Apr 1; 75(10):738-9.
    View PubMed
  67. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1995 Jan 15; 91(2):580-615.
    View PubMed
  68. Lee JY, Oberman A, Fletcher GF, Raczynski JM, Fletcher BJ, Nanda NC, Jensen BE. Design of the training levels comparison trial. Control Clin Trials. 1994 Feb; 15(1):59-76.
    View PubMed
  69. Fletcher BJ, Dunbar SB, Felner JM, Jensen BE, Almon L, Cotsonis G, Fletcher GF. Exercise testing and training in physically disabled men with clinical evidence of coronary artery disease. Am J Cardiol. 1994 Jan 15; 73(2):170-4.
    View PubMed
  70. Fletcher BJ, Dunbar S, Coleman J, Jann B, Fletcher GF. Cardiac precautions for non-acute inpatient settings. American Journal of Physical Medicine & Rehabilitation. 1993 Jun; 72(3):140-3.
    View PubMed
  71. Fletcher GF. The value of exercise in preventing coronary atherosclerotic heart disease. Heart Disease & Stroke. 1993 May-Jun; 2(3):183-7.
    View PubMed
  72. Fletcher GF, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, Falls H, Froelicher ES, Froelicher VF, Pina IL. Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. Circulation. 1992 Jul; 86(1):340-4.
    View PubMed
  73. Fletcher GF. Exercise for the coronary patient: Physiolgic basis. Cardiovascular Reviews & Reports. 1992; 13(8):12-23.
  74. Sweeney ME, Fletcher BJ, Rice CR, Berra KA, Rudd CM, Fletcher GF, Superko RS. Efficacy and compliance with cholestyramine bar versus powder in the treatment of hyperlipidemia. Am J Med. 1991 Apr; 90(4):469-73.
    View PubMed
  75. Fletcher GF. The exercise standards from the American Heart Association--a commentary. J Med Assoc Ga. 1991 Feb; 80(2):89-92.
    View PubMed
  76. Hill JO, Thiel J, Heller PA, Markon C, Fletcher G, DiGirolamo M. Energetic and metabolic studies of intragastric infusion of calories before and after exercise training. Int J Obes. 1991 Feb; 15(2):169-79.
    View PubMed
  77. Fletcher GF, Sweeney ME, Fletcher BJ. Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade. Am Heart J. 1991 Jan; 121(1 Pt 1):105-10.
    View PubMed
  78. Fletcher GF, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for health professionals from the American Heart Association. Circulation. 1990 Dec; 82(6):2286-322.
    View PubMed
  79. Fletcher GF, Fletcher BJ, Sweeney ME. Effects of exercise testing, training and beta blockade on serum potassium in normal subjects. Am J Cardiol. 1990 May 15; 65(18):1242-5.
    View PubMed
  80. McHenry PL, Ellestad MH, Fletcher GF, Froelicher V, Hartley H, Mitchell JH, Froelicher ES. Statement on exercise. A position statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1990 Jan; 81(1):396-8.
    View PubMed
  81. Sweeney ME, Fletcher BJ, Fletcher GF. Exercise testing and training with beta-adrenergic blockade: role of the drug washout period in "unmasking" a training effect. Am Heart J. 1989 Nov; 118(5 Pt 1):941-6.
    View PubMed
  82. Hill JO, Thiel J, Heller PA, Markon C, Fletcher G, DiGirolamo M. Differences in effects of aerobic exercise training on blood lipids in men and women. Am J Cardiol. 1989 Jan 15; 63(3):254-6.
    View PubMed
  83. Kinsey MA, Fletcher BJ, Rice CR, Watson PH, Fletcher GF. Coronary risk factor modification followed by home-monitored exercise in coronary bypass surgery patients: a four-year follow-up study. J Cardiopulm Rehabil. 1989; 9:207-12.
  84. Fletcher GF, Jensen B. Hyperlipidemia therapy; cost and patient management. Resid Staff Physician. 1989; 35(7):49-54.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.